Search Results

Oral contraceptives and venous thromboembolism: identifying the safest option

Author: Wu, Olivia

Source: Expert Review of Cardiovascular Therapy, Volume 7, Number 12, December 2009 , pp. 1513-1516(4)

Publisher: Expert Reviews

Oral hormonal contraceptives containing drospirenone have a comparative safety profile to that of other preparations currently available

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 3-3(1)

Publisher: Adis International

Ethinylestradiol/drospirenone: Deep vein thrombosis: case report

Source: Reactions, Volume 1, Number 1274, 2009-10-17 , pp. 21-21(1)

Publisher: Adis International

Drospirenone/ethinylestradiol/levonorgestrel: First report of corneal copper deposition and hypercupraemia: 2 case reports

Source: Reactions, Volume 1, Number 1268, 2009-09-05 , pp. 15-15(1)

Publisher: Adis International

Oral contraceptives: VT risk quantified

Source: Reactions, Volume 1, Number 1266, 2009-08-22 , pp. 1-1(1)

Publisher: Adis International

Ethinylestradiol/drospirenone: Venous thromboembolism: 8 case reports

Source: Reactions, Volume 1, Number 1267, 2009-08-29 , pp. 16-17(2)

Publisher: Adis International

Twenty or thirty microgram ethinyloestradiol in an oral contraceptive: Does it make a difference in the mind and the daily practise of gynaecologists and general practitioners?

Authors: Bitzer, J.; Frey, B.; von Schonau, M.; Sabler, N.; Tschudin, S.

Source: The European Journal of Contraception and Reproductive Health Care, Volume 14, Number 4, August 2009 , pp. 258-267(10)

Publisher: Informa Healthcare

Ethinylestradiol/drospirenone: Acute myocardial infarction: case report

Source: Reactions, Volume 1, Number 1264, 2009-08-08 , pp. 17-17(1)

Publisher: Adis International

Progestin may modify the effect of low-dose hormone therapy on mammographic breast density

Authors: Panoulis, C.; Lambrinoudaki, I.; Vourtsi, A.; Augoulea, A.; Kaparos, G.; Aravantinos, L.; Christodoulakos, G.; Creatsas, G.

Source: Climacteric, Volume 12, Number 3, June 2009 , pp. 240-247(8)

Publisher: Informa Healthcare

User Satisfaction with the Combined Oral Contraceptive Drospirenone 3 mg/Ethinylestradiol 20 μg (Yasminelle®) in Clinical Practice: A Multi-Country, Questionnaire-Based Study

Author: Short, Mary

Source: Clinical Drug Investigation, Volume 29, Number 3, 26 February 2009 , pp. 153-159(7)

Publisher: Adis International

Confluent and reticulated papillomatosis associated with polycystic ovary syndrome treated with a combined contraceptive containing drospirenone

Authors: Özdemir, S; Özdemir, M; Toy, H

Source: Journal of the European Academy of Dermatology & Venereology, Volume 23, Number 3, March 2009 , pp. 358-359(2)

Publisher: Blackwell Publishing

Effects of drospirenone on cardiovascular markers in human aortic endothelial cells

Authors: Seeger, H.; Wallwiener, D.; Mueck, A. O.

Source: Climacteric, Volume 12, Number 1, February 2009 , pp. 80-87(8)

Publisher: Informa Healthcare

Added Benefits and User Satisfaction with a Low-Dose Oral Contraceptive Containing Drospirenone: Results of Three Multicentre Trials

Authors: Bitzer, Johannes; Paoletti, Anna M.

Source: Clinical Drug Investigation, Volume 29, Number 2, 2009 , pp. 73-78(6)

Publisher: Adis International

Treatment of hirsutism with combined pill containing drospirenone

Authors: Gregoriou, Odisseas; Papadias, Kostantinos; Konidaris, Sokratis; Bakalianou, Kostantina; Salakos, Nikolaos; Vrachnis, Nikolaos; Creatsas, George

Source: Gynecological Endocrinology, Volume 24, Number 4, March 2008 , pp. 220-223(4)

Publisher: Informa Healthcare

Ethinylestradiol/drospirenone: Mood lability and first report of ovarian hyperstimulation in a patient with premature ovarian failure: case report

Source: Reactions, Volume 1, Number 1229, 2008-11-22 , pp. 13-14(2)

Publisher: Adis International

Ethinylestradiol/drospirenone: Essential thrombocythemia and splanchnic deep vein thrombosis in a patient with the Jak2 Val617Phe mutation: case report

Source: Reactions, Volume 1, Number 1211, 2008-07-19 , pp. 16-16(1)

Publisher: Adis International

Ethinylestradiol/drospirenone: First report of false-positive diagnosis of primary aldosteronism: case report

Source: Reactions, Volume 1, Number 1211, 2008-07-19 , pp. 16-16(1)

Publisher: Adis International

Ethinylestradiol/drospirenone effective contraceptive

Source: Inpharma, Volume 1, Number 1638, 2008-05-17 , pp. 7-7(1)

Publisher: Adis International

Use of the oral contraceptive ethinylestradiol/drospirenone is not associated with an increase in body weight.

Source: Inpharma, Volume 1, Number 1638, 2008-05-17 , pp. 12-12(1)

Publisher: Adis International

Ethinylestradiol/drospirenone [Yasmin] significantly decreases testosterone levels in patients with polycystic ovary syndrome

Source: Inpharma, Volume 1, Number 1638, 2008-05-17 , pp. 12-12(1)

Publisher: Adis International